YCBD cbdMD, Inc.

Overview and Growth

Fiscal 2025 results for cbdMD, Inc. combined $19.19M of revenue with net loss of $2.04M and an operating cash outflow of $1.45M. At $19.19M, the top line establishes the operating scale supporting the company’s profit and cash-flow profile. Revenue was 1.5% below fiscal 2024 revenue of $19.48M, marking a top-line contraction. Diluted earnings per share were -$1.09, translating the period’s attributable earnings into the amount reported for each diluted share. The company employed $10.42M of total assets, the balance-sheet base supporting its current operating and cash-flow results. Revenue equaled 1.84x of total assets, indicating how much reported top-line activity the company produced relative to its period-end asset base.

Profitability

Gross profit was $11.97M, representing the portion of revenue remaining after the reported cost of revenue and before operating expenses. Gross margin was 62.4%, so that share of each revenue unit remained after the cost of revenue reported for the period. The company recorded an operating loss of $2.16M after the reported operating expense base. Relative to revenue, the operating deficit measured 11.3%, showing the shortfall after operating costs. The company ended the period with a net loss of $2.04M, extending the operating result through all remaining items. Measured against revenue, the bottom-line deficit represented 10.6% after all recognized items. EBITDA was negative $1.80M, showing a deficit before interest, taxes, depreciation, and amortization. The company reported a pretax loss of $2.04M, before the effect of income taxes. Pretax margin was -10.6%, reflecting a pre-tax loss equal to 10.6% of revenue. The company recognized $0.00 of income tax for the period, completing the transition from pretax income to net income. The loss-to-equity relationship was 28.2%, placing the bottom-line deficit against shareholder capital. The net loss equaled 19.6% of period-end assets, showing the deficit relative to the asset base. The net loss narrowed to $2.04M from $3.70M in fiscal 2024.

Liquidity and Capital Structure

The company held $10.42M of assets against $3.19M of liabilities and $7.23M of equity, revealing how the asset base was financed. The near-term balance sheet paired $6.55M of current assets with $3.19M of current liabilities at the reporting date. At 2.05x, the current ratio shows that short-term assets were greater than short-term liabilities at period end. Reported cash and equivalents were $2.26M, separating immediately recognizable cash resources from the rest of the current-asset base. Cash and equivalents represented 70.8% of current liabilities, showing the portion of near-term obligations matched by reported cash alone. Equity equaled 69.3% of assets, showing the shareholder-capital layer within the company’s balance sheet. Relative to total assets, liabilities measured 30.7%, complementing the separate equity-based view of the company’s capital structure. The cash-to-assets relationship was 21.7%, comparing reported cash and equivalents with the full positive asset balance. The asset base changed 1.5% from $10.58M in fiscal 2024, leaving current total assets lower year over year. Book equity was 268.0% higher than fiscal 2024 equity of $1.96M, showing how shareholder capital changed year over year. The reported cash balance changed 7.8% from $2.45M in fiscal 2024, ending lower year over year.

Cash Flow and Earnings Quality

Operating activities used $1.45M of cash, resulting in an operating cash outflow for the year. Capital expenditures used $184.17K in addition to the operating cash outflow, increasing the total cash consumed by operations and investment during the period. The company recorded a $1.64M cash deficit after capital spending for the period. Relative to revenue, the post-investment cash deficit represented 8.5%. Relative to total assets, the post-investment cash deficit measured 15.7%.

Based on the annual report for the fiscal year ending Sep 30, 2025. Analysis generated Oct 21, 2026.